These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3828909)

  • 1. Implantable device for venous access.
    Leclerc YE; Loutfi A
    Can J Surg; 1987 Mar; 30(2):127-9. PubMed ID: 3828909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Totally implantable venous access systems. Analysis of complications].
    D'Angelo F; Ramacciato G; Caramitti A; Aurello P; Lauro S; Bordin F; Della Casa U
    Minerva Chir; 1997; 52(7-8):937-42. PubMed ID: 9411296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Insertion and management of long-term central venous devices: role of radiologic imaging techniques].
    Capaccioli L; Nistri M; Distante V; Rontini M; Manetti A; Stecco A
    Radiol Med; 1998 Oct; 96(4):369-74. PubMed ID: 9972217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experience with an implantable venous access system for chemotherapy.
    Pettengell R; Davies AJ; Harvey VJ
    N Z Med J; 1991 Jul; 104(915):284-5. PubMed ID: 1852329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Totally implanted device for long-term intravenous chemotherapy: experience in 123 adult patients with solid neoplasms.
    Puig-la Calle J; López Sánchez S; Piedrafita Serra E; Allende Honorato L; Artigas Raventós V; Puig la Calle J
    J Surg Oncol; 1996 Aug; 62(4):273-8. PubMed ID: 8691841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subcutaneously implanted central venous access devices in cancer patients: a prospective analysis.
    Schwarz RE; Groeger JS; Coit DG
    Cancer; 1997 Apr; 79(8):1635-40. PubMed ID: 9118051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility and complications of permanent venous access devices (PVAD) in oncological treatments. Follow-up of 100 cases.
    Groebli Y; Wutrich P; Safa M; Tschantz P; Callewaert G; Piguet D
    Panminerva Med; 1999 Jun; 41(2):89-92. PubMed ID: 10479903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cephalic vein access for implantable venous access devices. Technique and long-term follow-up].
    Conessa C; Talfer S; Herve S; Chollet O; Poncet JL
    Rev Laryngol Otol Rhinol (Bord); 2002; 123(3):143-8. PubMed ID: 12577777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Totally implantable venous access port systems and risk factors for complications: a one-year prospective study in a cancer centre.
    Narducci F; Jean-Laurent M; Boulanger L; El Bédoui S; Mallet Y; Houpeau JL; Hamdani A; Penel N; Fournier C
    Eur J Surg Oncol; 2011 Oct; 37(10):913-8. PubMed ID: 21831566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgically implanted subcutaneous venous access devices in cancer patients.
    Repelaer van Driel OJ; Kuin CM; van de Velde CJ
    Neth J Surg; 1988 Jun; 40(4):97-9. PubMed ID: 3217033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experience with the intravenous totally implanted port in patients with gynecologic malignancies.
    Nelson BE; Mayer AR; Tseng PC; Schwartz PE
    Gynecol Oncol; 1994 Apr; 53(1):98-102. PubMed ID: 8175028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Complications after insertion of a totally implantable venous access port in patients treated with chemotherapy for head and neck squamous cell carcinoma].
    Hoareau-Gruchet F; Rtail R; Sulaj H; Khirnetkina A; Reyt E; Righini CA
    Ann Otolaryngol Chir Cervicofac; 2009 Apr; 126(2):43-52. PubMed ID: 19324328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of silicone elastomer catheters for long-term intravenous chemotherapy.
    Legha SS; Haq M; Rabinowits M; Lawson M; McCredie K
    Arch Intern Med; 1985 Jul; 145(7):1208-11. PubMed ID: 4015268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inpatient and outpatient use of the Hickman catheter for adults with osteomyelitis.
    Couch L; Cierny G; Mader JT
    Clin Orthop Relat Res; 1987 Jun; (219):226-35. PubMed ID: 3581575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experience with implanted subcutaneous ports for intraperitoneal chemotherapy in ovarian cancer.
    Malmström H; Carstensen J; Simonsen E
    Gynecol Oncol; 1994 Jul; 54(1):27-34. PubMed ID: 8020835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical experience of a subcutaneously implantable drug delivery catheter (PORT-A-CATH)].
    Kimura K; Koide A; Suga S; Shimoyama T; Okamoto E; Utsunomiya J; Okawa T; Taguchi T; Wakui A
    Gan To Kagaku Ryoho; 1987 Apr; 14(4):1150-5. PubMed ID: 3566308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term experience with a totally implanted catheter system in gynecologic oncologic patients.
    Koonings PP; Given FT
    J Am Coll Surg; 1994 Feb; 178(2):164-6. PubMed ID: 8173727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of Hickman line- and Port-a-Cath-associated complications in patients with solid tumours undergoing chemotherapy.
    Ng F; Mastoroudes H; Paul E; Davies N; Tibballs J; Hochhauser D; Mayer A; Begent R; Meyer T
    Clin Oncol (R Coll Radiol); 2007 Sep; 19(7):551-6. PubMed ID: 17517500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxic therapy. Role of durable venous access.
    Rao VK; Charak BS; Giri NK; Banavali SD; Pai SK; Pai VR; Nadkarni KS; Kurkure PA; Saikia TK; Gopal R
    J Assoc Physicians India; 1990 Dec; 38(12):897-9. PubMed ID: 2096122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Totally implantable venous-access systems: apropos of experiences of 30 patients].
    Perrot D; Coiffier B; Brudon JR; Motin J; Viala JJ
    Ann Med Interne (Paris); 1987; 138(1):19-25. PubMed ID: 3109299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.